Results

Athira Pharma Inc.

06/22/2022 | Press release | Distributed by Public on 06/22/2022 05:09

Athira Pharma Announces Topline Results from ACT-AD Phase 2 Proof of Concept Study of Fosgonimeton in Mild-to-Moderate Alzheimer’s Disease